49
Views
62
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression

, , , , , , & show all
Pages 7450-7459 | Received 14 Jun 2000, Accepted 21 Jul 2000, Published online: 28 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ruili Yu, Tingyi Sun, Xianwei Zhang, Zhen Li, Yang Xu, Kaihua Liu, Yuqian Shi, Xue Wu, Yang Shao & Lingfei Kong. (2021) TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer. OncoTargets and Therapy 14, pages 4967-4978.
Read now
Donato F. Romagnolo, Ryan B. Chirnomas, Jennifer Ku, Brandon D. Jeffy, Claire M. Payne, Hana Holubec, Lois Ramsey, Harris Bernstein, Carol Bernstein, Kathleen Kunke, Achyut Bhattacharyya, James Warneke & Harinder Garewal. (2003) Deoxycholate, an Endogenous Tumor Promoter and DNA Damaging Agent, Modulates BRCA-1 Expression in Apoptosis-Sensitive Epithelial Cells: Loss of BRCA-1 Expression in Colonic Adenocarcinomas. Nutrition and Cancer 46:1, pages 82-92.
Read now
Timothy K. MacLachlan, Rishu Takimoto & Wafik S. El-Deiry. (2002) BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets. Molecular and Cellular Biology 22:12, pages 4280-4292.
Read now

Articles from other publishers (59)

Juliana Calheiros, Vincenzo Corbo & Lucília Saraiva. (2023) Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188914.
Crossref
Jie Wang, Zhijian Zheng, Xiaopei Cui, Chaochao Dai, Jiaxin Li, Qunye Zhang, Mei Cheng & Fan Jiang. (2022) A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage. Frontiers in Pharmacology 13.
Crossref
Lilith Trassl & Georgios T. Stathopoulos. (2022) KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player. Cancers 14:17, pages 4303.
Crossref
Rossella Benedetti, Maria Anele Romeo, Andrea Arena, Maria Saveria Gilardini Montani, Livia Di Renzo, Gabriella D’Orazi & Mara Cirone. (2022) ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress. Cell Death Discovery 8:1.
Crossref
Maria Russi, Domenico Marson, Alice Fermeglia, Suzana Aulic, Maurizio Fermeglia, Erik Laurini & Sabrina Pricl. (2022) The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacology & Therapeutics 232, pages 108009.
Crossref
Maria Anele Romeo, Maria Saveria Gilardini Montani, Rossella Benedetti, Andrea Arena, Gabriella D’Orazi & Mara Cirone. (2022) VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor. International Journal of Molecular Sciences 23:4, pages 2268.
Crossref
Antonia Marazioti, Anthi C Krontira, Sabine J Behrend, Georgia A Giotopoulou, Giannoula Ntaliarda, Christophe Blanquart, Hasan Bayram, Marianthi Iliopoulou, Malamati Vreka, Lilith Trassl, Mario A A Pepe, Caroline M Hackl, Laura V Klotz, Stefanie A I Weiss, Ina Koch, Michael Lindner, Rudolph A Hatz, Juergen Behr, Darcy E Wagner, Helen Papadaki, Sophia G Antimisiaris, Didier Jean, Sophie Deshayes, Marc Grégoire, Özgecan Kayalar, Deniz Mortazavi, Şükrü Dilege, Serhan Tanju, Suat Erus, Ömer Yavuz, Pınar Bulutay, Pınar Fırat, Ioannis Psallidas, Magda Spella, Ioanna Giopanou, Ioannis Lilis, Anne‐Sophie Lamort & Georgios T Stathopoulos. (2021) KRAS signaling in malignant pleural mesothelioma. EMBO Molecular Medicine 14:2.
Crossref
Antons Martincuks, Jieun Song, Adrian Kohut, Chunyan Zhang, Yi-Jia Li, Qianqian Zhao, Edward Mak, Lorna Rodriguez-Rodriguez, Hua Yu & Mihaela Cristea. (2021) PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer. Frontiers in Oncology 11.
Crossref
Geralle Powell, Slavica Pavlovic Djuranovic & Sergej Djuranovic. (2021) Gene dosage effects of poly(A) track-engineered hypomorphs. Molecular Therapy - Nucleic Acids 26, pages 865-878.
Crossref
Maria Anele Romeo, Maria Saveria Gilardini Montani, Rossella Benedetti, Andrea Arena, Mara Maretto, Erica Bassetti, Rossella Caiazzo, Gabriella D'Orazi & Mara Cirone. (2021) Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53. Experimental Cell Research 408:2, pages 112879.
Crossref
Marta San Martin Alonso & Sylvie M Noordermeer. (2021) Untangling the crosstalk between BRCA1 and R-loops during DNA repair. Nucleic Acids Research 49:9, pages 4848-4863.
Crossref
M. Zubair, S. Wang & N. Ali. (2021) Advanced Approaches to Breast Cancer Classification and Diagnosis. Frontiers in Pharmacology 11.
Crossref
Ayelet Avraham, Susanna Feldman, Sean Soonweng Cho, Ayala Kol, Lior Heler, Emmanuela Riklin-Nahmias, Avishay Sella, Tamar Karni, Tanir M. Allweis, Saraswati Sukumar & Ella Evron. (2020) Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells. Cancers 12:9, pages 2367.
Crossref
F Strube, M Infanger, C Dietz, A Romswinkel & A Kraus. (2020) Short-term effects of simulated microgravity on morphology and gene expression in human breast cancer cells. Physiology International 106:4, pages 311-322.
Crossref
Jianbin Guo, Ying Zhang, Haili Qian, Fei Ma, Xiujuan Cui & Hua Duan. (2019) The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?. Archives of Gynecology and Obstetrics 300:5, pages 1399-1404.
Crossref
Pascal H.G. Duijf, Devathri Nanayakkara, Katia Nones, Sriganesh Srihari, Murugan Kalimutho & Kum Kum Khanna. (2019) Mechanisms of Genomic Instability in Breast Cancer. Trends in Molecular Medicine 25:7, pages 595-611.
Crossref
Keng Po Lai, Simon Yuan Wang, Jing Woei Li, Yin Tong, Ting Fung Chan, Nana Jin, Anna Tse, Jiang Wen Zhang, Miles Teng Wan, Nathan Tam, Doris Wai Ting Au, Bo-Young Lee, Jae-Seong Lee, Alice Sze Tsai Wong, Richard Yuen Chong Kong & Rudolf Shiu Sun Wu. (2019) Hypoxia Causes Transgenerational Impairment of Ovarian Development and Hatching Success in Fish. Environmental Science & Technology 53:7, pages 3917-3928.
Crossref
Xiaowen Zhang & Rong Li. (2018) BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression. Cancers 10:12, pages 513.
Crossref
Joe R. Delaney & Dwayne G. Stupack. 2018. Ovarian Cancer - From Pathogenesis to Treatment. Ovarian Cancer - From Pathogenesis to Treatment.
Meryam El Khachibi, Mohamed El Karroumi, Salah Eddine Ayoubi, Nadia El Kadmiri & Sellama Nadifi. (2018) Assessment of the expression of the BRCA1, BRCA2, TP53, MDM2, BAX and CASP-3 genes in normal and tumor tissues for patients with breast cancer in Morocco. Gene Reports 10, pages 47-53.
Crossref
Xi Zhang, Simone Hofmann, Nadia Harbeck, Udo Jeschke & Sophie Sixou. (2017) Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines. Drugs in R&D 17:4, pages 569-583.
Crossref
Weng Howe Chan, Mohd Saberi Mohamad, Safaai Deris, Nazar Zaki, Shahreen Kasim, Sigeru Omatu, Juan Manuel Corchado & Hany Al Ashwal. (2016) Identification of informative genes and pathways using an improved penalized support vector machine with a weighting scheme. Computers in Biology and Medicine 77, pages 102-115.
Crossref
Sylvie Moureau, Janna Luessing, Emma Christina Harte, Muriel Voisin & Noel Francis Lowndes. (2016) A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining. Open Biology 6:9, pages 160225.
Crossref
Aye A. Thike, Puay H. Tan, Murasaki Ikeda & Jabed Iqbal. (2016) Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival. Histopathology 68:5, pages 702-712.
Crossref
HEMANT SARIN. (2016) Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells. Molecular and Clinical Oncology 4:3, pages 326-368.
Crossref
Chao Dong, Fengmei Zhang, Yue Luo, Hui Wang, Xipeng Zhao, Gongshe Guo, Simon N. Powell & Zhihui Feng. (2015) p53 suppresses hyper-recombination by modulating BRCA1 function. DNA Repair 33, pages 60-69.
Crossref
Kyoung Wan YoonSanguine ByunEunjeong KwonSo-Young HwangKiki ChuMasatsugu HirakiSeung-Hee JoAstrid WeinsSamy HakroushAngelika CebullaDavid B. SykesAnna GrekaPeter MundelDavid E. FisherAnna MandinovaSam W. Lee. (2015) Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science 349:6247.
Crossref
Jie Li, Lixin Yang, Shikha Gaur, Keqiang Zhang, Xiwei Wu, Yate-Ching Yuan, Hongzhi Li, Shuya Hu, Yaguang Weng & Yun Yen. (2014) Mutants TP53 p.R273H and p.R273C but not p.R273G Enhance Cancer Cell Malignancy. Human Mutation 35:5, pages 575-584.
Crossref
Yunguang Sun, Carey Jeanne Myers, Adam Paul Dicker & Bo Lu. (2014) A Novel Radiation-Induced p53 Mutation Is Not Implicated in Radiation Resistance via a Dominant-Negative Effect. PLoS ONE 9:2, pages e87492.
Crossref
Gaël A. Millot, Marcelo A. Carvalho, Sandrine M. Caputo, Maaike P.G. Vreeswijk, Melissa A. Brown, Michelle Webb, Etienne Rouleau, Susan L. Neuhausen, Thomas v. O. Hansen, Alvaro Galli, Rita D. Brandão, Marinus J. Blok, Aneliya Velkova, Fergus J. Couch & Alvaro N.A. Monteiro. (2012) A guide for functional analysis of BRCA1 variants of uncertain significance . Human Mutation 33:11, pages 1526-1537.
Crossref
Christoforos G. Thomas, Anders Strom, Karolina Lindberg & Jan-Ake Gustafsson. (2010) Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling. Breast Cancer Research and Treatment 127:2, pages 417-427.
Crossref
Levin Böhlig & Karen Rother. (2011) One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor. Journal of Biomedicine and Biotechnology 2011, pages 1-15.
Crossref
Ekram M. Saleh, Raafat A. El-Awady, Mervat A. Abdel Alim & Abdel Hady A. Abdel Wahab. (2009) Altered Expression of Proliferation-Inducing and Proliferation-Inhibiting Genes Might Contribute to Acquired Doxorubicin Resistance in Breast Cancer Cells. Cell Biochemistry and Biophysics 55:2, pages 95-105.
Crossref
Rainer Girgert, Volker Hanf, Günter Emons & Carsten Gründker. (2009) Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. Journal of Pineal Research 47:1, pages 23-31.
Crossref
M. Wang, B. Yu, K. Westerlind, R. Strange, G. Khan, D. Patil, K. Boeneman & L. Hilakivi-Clarke. (2008) Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland. Breast Cancer Research and Treatment 115:1, pages 213-220.
Crossref
Matteo Rossi, Oleg N. Demidov, Carl W. Anderson, Ettore Appella & Sharlyn J. Mazur. (2008) Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Research 36:22, pages 7168-7180.
Crossref
Yukihiko Dan, Yutaka Ohta, Daisuke Tsuchimoto, Mizuki Ohno, Yasuhito Ide, Manabu Sami, Tomomasa Kanda, Kunihiko Sakumi & Yusaku Nakabeppu. (2008) Altered gene expression profiles and higher frequency of spontaneous DNA strand breaks in APEX2-null thymus. DNA Repair 7:9, pages 1437-1454.
Crossref
Hirokuni ShinagawaYoshio MikiKiyotsugu Yoshida. (2008) BRCA1-Mediated Ubiquitination Inhibits Topoisomerase II α Activity in Response to Oxidative Stress . Antioxidants & Redox Signaling 10:5, pages 939-950.
Crossref
Kimberly A. Scata & Wafik S. El-Deiry. 2007. Breast Cancer Chemosensitivity. Breast Cancer Chemosensitivity 70 86 .
Paul B. Mullan, Julia J. Gorski & D. Paul Harkin. (2006) BRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1766:2, pages 205-216.
Crossref
Chen Glait, Dana Ravid, Sam W. Lee, Mordechai Liscovitch & Haim Werner. (2006) Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells. FEBS Letters 580:22, pages 5268-5274.
Crossref
Rive Sarfstein, Sharon Maor, Naama Reizner, Shirley Abramovitch & Haim Werner. (2006) Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer. Molecular and Cellular Endocrinology 252:1-2, pages 241-246.
Crossref
Brandon D. Jeffy, Jennifer K. Hockings, Michael Q. Kemp, Sherif S. Morgan, Jill A. Hager, Jason Beliakoff, Luke J. Whitesell, G. Timothy Bowden & Donato F. Romagnolo. (2005) An Estrogen Receptor-α/p300 Complex Activates the BRCA-1 Promoter at an AP-1 Site That Binds Jun/Fos Transcription Factors: Repressive Effects of p53 on BRCA-1 Transcription. Neoplasia 7:9, pages 873-882.
Crossref
D. Wells, M.G. Bermudez, N. Steuerwald, A.R. Thornhill, D.L. Walker, H. Malter, J.D.A. Delhanty & J. Cohen. (2005) Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development. Human Reproduction 20:5, pages 1339-1348.
Crossref
Timothy MacLachlan & Wafik El-Deiry. 2005. The p53 Tumor Suppressor Pathway and Cancer. The p53 Tumor Suppressor Pathway and Cancer 53 80 .
Susanne Stein, Emily K. Thomas, Birger Herzog, Matthew D. Westfall, Jonathan V. Rocheleau, Roger S. JacksonIIII, Mai Wang & Peng Liang. (2004) NDRG1 Is Necessary for p53-dependent Apoptosis. Journal of Biological Chemistry 279:47, pages 48930-48940.
Crossref
Zhihui Feng, Lisa Kachnic, Junran Zhang, Simon N. Powell & Fen Xia. (2004) DNA Damage Induces p53-dependent BRCA1 Nuclear Export. Journal of Biological Chemistry 279:27, pages 28574-28584.
Crossref
Vanesa Garcia, Gemma Domínguez, José M García, Javier Silva, Cristina Peña, José M Silva, Enric Carcereny, Josefa Menendez, Pilar España & Félix Bonilla. (2004) Altered expression of the ZBRK1 gene in human breast carcinomas . The Journal of Pathology 202:2, pages 224-232.
Crossref
Shanthi Adimoolam & James M. Ford. (2003) p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair 2:9, pages 947-954.
Crossref
Kristina Löhr, Constanze Möritz, Ana Contente & Matthias Dobbelstein. (2003) p21/CDKN1A Mediates Negative Regulation of Transcription by p53. Journal of Biological Chemistry 278:35, pages 32507-32516.
Crossref
Mel Campbell, Shimian Qu, Sam Wells, Herlina Sugandha & Roy A Jensen. (2003) An adenoviral vector containing an arg–gly–asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression. Cancer Gene Therapy 10:7, pages 559-570.
Crossref
Eliot M. Rosen, Saijun Fan, Richard G. Pestell & Itzhak D. Goldberg. (2003) BRCA1 gene in breast cancer. Journal of Cellular Physiology 196:1, pages 19-41.
Crossref
Pat P Ongusaha, Toru Ouchi, Kyung-tae Kim, Emily Nytko, Jennifer C Kwak, Rosemary B Duda, Chu-Xia Deng & Sam W Lee. (2003) BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene 22:24, pages 3749-3758.
Crossref
Matthew T. Canning, David A. Brown & Daniel B. Yarosh. (2003) A Bicyclic Monoterpene Diol and UVB Stimulate BRCA1 Phosphorylation in Human Keratinocytes¶. Photochemistry and Photobiology 77:1, pages 46-51.
Crossref
Dianne C. Daniel. (2002) Highlight: BRCA1 and BRCA2 proteins in breast cancer. Microscopy Research and Technique 59:1, pages 68-83.
Crossref
Xiaoping Sun, Yun Gong, M. Sambasiva Rao & Sunil Badve. (2002) Loss of BRCA1 expression in sporadic male breast carcinoma. Breast Cancer Research and Treatment 71:1, pages 1-7.
Crossref
Brandon D. Jeffy, Ryan B. Chirnomas & Donato F. Romagnolo. (2002) Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors. Environmental and Molecular Mutagenesis 39:2-3, pages 235-244.
Crossref
Zoe A. Stewart & Jennifer A. Pietenpol. (2001) p53 Signaling and Cell Cycle Checkpoints. Chemical Research in Toxicology 14:3, pages 243-263.
Crossref
Timothy K. MacLachlan & Wafik S. El-Deiry. (2000) Pointing (zinc) fingers at BRCA1 targets. Nature Medicine 6:12, pages 1318-1319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.